CDC Alert: B-Cell Depleting Therapies Raise Risk of Severe Arboviral Neuroinvasive Disease
The CDC issued a warning about the risk of severe arboviral neuroinvasive disease in patients receiving B cell-depleting or modulating agents, particularly anti-CD20 monoclonal antibodies. The advisory was based on published case reports highlighting the danger.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “CDC Warns of Severe Arboviral Disease With B-Cell Drugs.” Browse more stories.